Saba Capital Management, Reported A 5.31% Stake In abrdn Life Sciences
$HQL
Investment Managers
Finance
-13D
-13D
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
PHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on March 31, 2026 to all shareholders of rec
PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 12, 2026, on a per share basis to all shareholders of record as of December 31, 2025 (ex-dividend date December 31, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on January 12, 2026, to all shareholders of record as of November 21, 2025 (ex-dividend da
PHILADELPHIA, Nov. 11, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on November 28, 2025 to all shareholders of record as of November 21, 2025 (ex-dividend date November 21, 2025). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on January 12, 2026, to all shareholders of
3 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
N-CSR - abrdn Life Sciences Investors (0000884121) (Filer)
N-CEN - abrdn Life Sciences Investors (0000884121) (Filer)
N-PX - abrdn Life Sciences Investors (0000884121) (Filer)
PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has
PHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on March 31, 2026 to all shareholders of rec
PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 12, 2026, on a per share basis to all shareholders of record as of December 31, 2025 (ex-dividend date December 31, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on January 12, 2026, to all shareholders of record as of November 21, 2025 (ex-dividend da
PHILADELPHIA, Nov. 11, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on November 28, 2025 to all shareholders of record as of November 21, 2025 (ex-dividend date November 21, 2025). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on January 12, 2026, to all shareholders of
SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)
SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)
SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)